Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750642 · ClinicalTrials.gov registry record · NA
Cochlear Implant With Dexamethasone Eluting Electrode Array
A NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 8
- Study locations
NCT04750642: Completed NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss, sponsored by Cochlear.
NCT04750642 is a NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss that has completed, run by Cochlear. The registered enrollment target is 42 participants, below the 128-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (67% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04750642, a NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 8
- Study locations
Study Summary
An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
Primary Outcome
The impedance was measured across the active electrodes of the cochlear implant for each participant. Reduced impedances indicate less fibrotic obstruction caused by trauma associated with the electrode insertion.
Conditions Studied
Interventions
- DEVICE CI632D
- DEVICE CI632
Study Locations (8)
New York
- New York Eye & Ear infirmary of Mt. Sinai - New York
- NYU Langone Medical Center - New York
New South Wales
- Fiona Stanley Hospital - Murdoch
- Westmead Hospital - Sydney
Colorado
- Rocky Mountain Ear Centre - Englewood
Iowa
- University of Iowa - Iowa City
Victoria
- Royal Victorian Eye and Ear Hospital - East Melbourne
Other
- Gilles Hospital - Auckland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
What the finished NCT04750642 record still lists
NCT04750642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 128-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which CI632D is the first listed.
NCT04750642 lists 8 locations in 6 states (New York, New South Wales, Colorado).
Frequently Asked Questions
What is clinical trial NCT04750642 about?
NCT04750642 is a clinical study titled "Cochlear Implant With Dexamethasone Eluting Electrode Array". An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
What is the current status of trial NCT04750642?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-10-04. Estimated completion is 2024-02-23.
What conditions does trial NCT04750642 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral Hearing Loss.
What interventions are being tested in trial NCT04750642?
The interventions under investigation include: CI632D (DEVICE), CI632 (DEVICE).
Who is sponsoring clinical trial NCT04750642?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04750642 being conducted?
This trial has 8 study locations across Colorado, Iowa, New York, New South Wales, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04750642's enrollment target sits among peer trials
42 9th of 13 higher than 5 of 13 other Sensorineural Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
RECRUITING · NA
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
The Effect of Sound Stimulation on Pure-tone Hearing Threshold
COMPLETED · NA
-
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI